Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

6051
1
nVent Electric plc nVent Electric Reports 12.6% Revenue Growth to $3.006 Billion for Fiscal Year 2024

Via official filing (AI summary) | 3 months ago | 0 comments

6052
1
BlueLinx Holdings Inc. BlueLinx Holdings Reports $2.95 Billion in Net Sales for Fiscal 2024, Net Income Rises to $53.1 Million

Via official filing (AI summary) | 3 months ago | 0 comments

6053
1
STANLEY BLACK & DECKER, INC. Stanley Black & Decker Reports $15.4 Billion Revenue for Fiscal Year 2024, Down 3%

Via official filing (AI summary) | 3 months ago | 0 comments

6054
1
Axsome Therapeutics, Inc. Axsome Therapeutics Reports $287.2 Million Net Loss and $381.7 Million Revenue for Fiscal Year 2024

Via official filing (AI summary) | 3 months ago | 0 comments

6055
1
Arteris, Inc. Arteris Reports 8% Revenue Growth to $57.7 Million, Net Loss Improves

Via official filing (AI summary) | 3 months ago | 0 comments

6056
1
CENTENE CORP Centene Corporation Reports 6% Revenue Growth to $163.1 Billion for Fiscal Year 2024

Via official filing (AI summary) | 3 months ago | 0 comments

6057
1
Penumbra Inc Penumbra Reports $1.19 Billion Revenue for Fiscal Year 2024, 12.9% Increase

Via official filing (AI summary) | 3 months ago | 0 comments

6058
1
TPG RE Finance Trust, Inc. TPG RE Finance Trust Reports $59.7M Net Income for 2024, Declares $78.7M in Dividends

Via official filing (AI summary) | 3 months ago | 0 comments

6059
1
WEST PHARMACEUTICAL SERVICES INC West Pharmaceutical Services Reports $2.89 Billion in Net Sales for Fiscal Year 2024

Via official filing (AI summary) | 3 months ago | 0 comments

6060
1
MEDIFAST INC Medifast Reports 43.8% Revenue Decline and Strategic Initiatives for Recovery

Via official filing (AI summary) | 3 months ago | 0 comments

6061
1
TWO HARBORS INVESTMENT CORP. Two Harbors Investment Corp. Reports $107.6 Million Comprehensive Income for Fiscal Year 2024

Via official filing (AI summary) | 3 months ago | 0 comments

6062
1
Confluent, Inc. Confluent Reports $963.6 Million Revenue for 2024, 24% Increase Year-Over-Year

Via official filing (AI summary) | 3 months ago | 0 comments

6063
1
CISCO SYSTEMS, INC. Cisco Systems Reports Q2 Fiscal 2025 Revenue Growth of 9% to $13.99 Billion

Via official filing (AI summary) | 3 months ago | 0 comments

6064
1
MOLSON COORS BEVERAGE CO Molson Coors Reports $11.6 Billion in Net Sales for 2024, Net Income Increases 18.3%

Via official filing (AI summary) | 3 months ago | 0 comments

6065
1
Community Healthcare Trust Inc Community Healthcare Trust Reports $3.2 Million Net Loss for Fiscal Year 2024

Via official filing (AI summary) | 3 months ago | 0 comments

6066
1
Seven Hills Realty Trust Seven Hills Realty Trust Reports 7.7% Revenue Decline to $35.3 Million for Fiscal Year 2024

Via official filing (AI summary) | 3 months ago | 0 comments

6067
1
CENTERSPACE Centerspace Reports Net Loss of $1.27 per Share for Fiscal Year 2024

Via official filing (AI summary) | 3 months ago | 0 comments

6068
1
UNITED PARCEL SERVICE INC UPS Reports $91.1 Billion Revenue with 13.8% Net Income Decline for Fiscal Year 2024

Via official filing (AI summary) | 3 months ago | 0 comments

6069
1
CASELLA WASTE SYSTEMS INC Casella Waste Systems Reports 26.2% Revenue Growth to $1.56 Billion in Fiscal Year 2024

Via official filing (AI summary) | 3 months ago | 0 comments

6070
1
OCCIDENTAL PETROLEUM CORP /DE/ Occidental Petroleum Reports $26.7 Billion Revenue for Fiscal Year 2024, Down from $28.3 Billion

Via official filing (AI summary) | 3 months ago | 0 comments

6071
1
Oric Pharmaceuticals, Inc. Oric Pharmaceuticals Reports $127.8 Million Net Loss for 2024, Driven by Increased R&D Expenses

Via official filing (AI summary) | 3 months ago | 0 comments

6072
1
LA-Z-BOY INC La-Z-Boy Reports 4.3% Revenue Growth to $521.8 Million in Q3 Fiscal 2025

Via official filing (AI summary) | 3 months ago | 0 comments

6073
1
FLOWERS FOODS INC Flowers Foods Reports Slight Revenue Increase and Plans Acquisition of Simple Mills

Via official filing (AI summary) | 3 months ago | 0 comments

6074
1
NEOGENOMICS INC NeoGenomics Reports 11.6% Revenue Increase to $660.6 Million for Fiscal Year 2024

Via official filing (AI summary) | 3 months ago | 0 comments

6075
1
HALOZYME THERAPEUTICS, INC. Halozyme Therapeutics Reports 22% Revenue Growth to $1.015 Billion in 2024

Via official filing (AI summary) | 3 months ago | 0 comments